Aspira Women’s Health (NASDAQ:AWH – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Aspira Women’s Health to post earnings of ($0.21) per share and revenue of $3.00 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Aspira Women’s Health Stock Performance
NASDAQ AWH opened at $0.12 on Thursday. The stock has a market capitalization of $2.09 million, a P/E ratio of -0.10 and a beta of 1.57. Aspira Women’s Health has a 1 year low of $0.11 and a 1 year high of $3.81. The business’s fifty day moving average is $0.32 and its two-hundred day moving average is $0.64.
Analyst Upgrades and Downgrades
Separately, StockNews.com assumed coverage on shares of Aspira Women’s Health in a research note on Sunday, January 12th. They set a “hold” rating on the stock.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Featured Articles
- Five stocks we like better than Aspira Women’s Health
- What Makes a Stock a Good Dividend Stock?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How Investors Can Find the Best Cheap Dividend Stocks
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
